Chapter

7. Inluriyo Plus Verzenio for ESR1-Mutated Breast Cancer

From 10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE by 10 Cancer Treatment Approvals From September 2026 and What They Mean for You

Concepts

1. Treatment Combination

   "This all-oral combination is for ER-positive, HER2-negative, ESR1-mutated advanced breast cancer that has grown after at least one hormone therapy. In EMBER-3, people with ESR1 mutations went a media

2. Treatment Options

   "What it means for you: It's the second ESR1-focused breast cancer approval this month, and both are pills, which can mean fewer infusion visits. CURE's 5 Years of Breast Cancer Advances explains how